T1	Participants 319 348	lupus erythematosus patients.
T2	Participants 447 523	32 individuals were randomized in a placebo controlled, double-blind setting
T3	Participants 780 793	placebo group
T4	Participants 935 950	vitamin D group
T5	Participants 1168 1179	both groups
